We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

18 hedge funds and large institutions have $326K invested in AIM ImmunoTech in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more capital invested

Capital invested by funds: $103K → $326K (+$223K)

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

1.23% less ownership

Funds ownership: 5.36% → 4.14% (-1.2%)

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$360K
2
VF
Virtu Financial
New York
+$33.5K
3
Morgan Stanley
Morgan Stanley
New York
+$22.8K
4
Goldman Sachs
Goldman Sachs
New York
+$14.8K
5
UBS Group
UBS Group
Switzerland
+$13.2K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$15K
2
XT
XTX Topco
Cayman Islands
-$12K
3
NA
NewEdge Advisors
Louisiana
-$2.92K
4
SPIA
Steward Partners Investment Advisory
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$229K +$360K +787,838 +3,930%
VF
2
Virtu Financial
New York
$35K +$33.5K +73,374 +144%
Morgan Stanley
3
Morgan Stanley
New York
$14.4K +$22.8K +50,000 +5,787%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$13.1K +$7.35K +16,085 +54%
Goldman Sachs
5
Goldman Sachs
New York
$9.21K +$14.8K +32,444 New
UBS Group
6
UBS Group
Switzerland
$8.22K +$13.2K +28,930 +2,893,000%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$6.21K +$9.99K +21,859 New
Vanguard Fiduciary Trust
8
Vanguard Fiduciary Trust
Pennsylvania
$4.97K – – –
GSC
9
Ground Swell Capital
South Carolina
$3.47K +$5.58K +12,222 New
TRCT
10
Tower Research Capital (TRC)
New York
$1.33K – – –
CA
11
Continuum Advisory
Idaho
$142 +$228 +500 New
CB
12
Community Bank
New York
$36 – – –
CFD
13
Creative Financial Designs
Indiana
$9 – – –
HI
14
Harbour Investments
Wisconsin
$9 – – –
HI
15
Hoey Investments
Pennsylvania
$3 – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$3 – – –
HF
17
HRT Financial
New York
– -$15K -26,032 Closed
XT
18
XTX Topco
Cayman Islands
– -$12K -20,590 Closed
NA
19
NewEdge Advisors
Louisiana
– -$2.92K -5,000 Closed
SPIA
20
Steward Partners Investment Advisory
New York
– -$1 -2 Closed

AIM Hedge Fund Activity: Q2 2026 in Review

18 of the 8,153 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2026, worth a combined $326K — up 217% from $103K a quarter earlier.

Fund positioning in AIM was balanced in Q2 2026: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, adding an estimated $360K. The largest seller was HRT Financial, exiting entirely with an estimated $15K sold.

  • 18 institutional investors held AIM ImmunoTech (AIM) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $326K of AIM ImmunoTech stock for Q2 2026, up 217% quarter-over-quarter.
  • 4 funds opened new AIM ImmunoTech positions in Q2 2026 and 4 closed out, a net change of 0 holders.
  • The largest AIM ImmunoTech buyer in Q2 2026 was Jane Street, an estimated $360K added.
  • The largest AIM ImmunoTech seller in Q2 2026 was HRT Financial, an estimated $15K sold.

Based on aggregated 13F filings for Q2 2026.